Foucher P, Baudouin N, Merati M, Pitard A, Bonniaud P, Reybet-Degat O, Jeannin L
Department of Pulmonary Diseases, University Hospital, Dijon, France.
Chest. 1998 Jun;113(6):1580-7. doi: 10.1378/chest.113.6.1580.
A survival analysis was conducted on patients with COPD receiving long-term oxygen therapy (LTOT) to compare two different statistical methods.
We used a multivariate crude (observed) survival model (Cox) and a multivariate relative survival model (Hakulinen). Only the latter is able to correct the survival by adjusting it to the normal life expectancy of the studied patients.
Two hundred fifty-two hypoxemic COPD patients (207 male) requiring LTOT were included. Mean PaO2 was <50 mm Hg before oxygen therapy. Mean age was >69 years (SE: 9.9). They had severe bronchial obstruction: mean FEV1 was <33% (10.6) of predicted values, with some CO2 retention: mean PaCO2 was 45.6 (7.1) mm Hg. By December 31, 1995, 189 patients had died (75%) and 13 (5%) were unavailable for follow-up.
The overall crude survival was poor: 80.9% after 1 year, 67.1% after 2 years, 34.7% after 5 years, and 7.1% after 10 years. In the crude multivariate analysis (Cox), the negative prognostic factors were age and hypercapnia. The overall relative survival (Hakulinen), corrected for life expectancy, was 82.8% after 1 year, 70.8% after 2 years, 41.5% after 5 years, and 10.25% after 10 years. In the final multivariate relative model, age was no longer significant and the only bad prognostic factor was hypercapnia with a relative risk of 1.97 (1.16 to 3.34).
This work shows the inadequacy of the Cox observed survival model when it comes to appreciating the real prognostic impact of age, because of the confusing factor associated with a normal life expectancy.
对接受长期氧疗(LTOT)的慢性阻塞性肺疾病(COPD)患者进行生存分析,以比较两种不同的统计方法。
我们使用了多变量粗(观察)生存模型(Cox)和多变量相对生存模型(Hakulinen)。只有后者能够通过将生存情况调整为所研究患者的正常预期寿命来校正生存情况。
纳入了252例需要LTOT的低氧血症COPD患者(207例男性)。氧疗前平均动脉血氧分压(PaO2)<50 mmHg。平均年龄>69岁(标准误:9.9)。他们存在严重的支气管阻塞:平均第1秒用力呼气容积(FEV1)<预测值的33%(10.6),伴有一定的二氧化碳潴留:平均动脉血二氧化碳分压(PaCO2)为45.6(7.1)mmHg。到1995年12月31日,189例患者死亡(75%),13例(5%)失访。
总体粗生存率较低:1年后为80.9%,2年后为67.1%,5年后为34.7%,10年后为7.1%。在粗多变量分析(Cox)中,负面预后因素为年龄和高碳酸血症。校正预期寿命后的总体相对生存率(Hakulinen)在1年后为82.8%,2年后为70.8%,5年后为41.5%,10年后为10.25%。在最终的多变量相对模型中,年龄不再具有显著性,唯一的不良预后因素是高碳酸血症,相对风险为1.97(1.16至3.34)。
这项研究表明,由于与正常预期寿命相关的混淆因素,Cox观察生存模型在评估年龄的实际预后影响方面存在不足。